Omada Health to Participate in J.P. Morgan Healthcare Conference
Omada Health (NASDAQ: OMDA) announced senior management will participate in the 44th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Omada Health (NASDAQ: OMDA) announced senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco.
The company will present on Wednesday, Jan. 14, 2026 at 9:00 a.m. PST. A live webcast and subsequent replay will be available at https://investors.omadahealth.com/news-events/events.
Details
News Market Reaction – OMDA
On Dec 22, the day this news came out, OMDA closed 6.83% above the previous close.
Data tracked by StockTitan Argus for the Dec 22 session.
Key Figures
- Conference edition
- 44th Annual J.P. Morgan Healthcare Conference
- Event participation announced in release
- Presentation time
- 9 a.m. PST
- Scheduled on Wednesday, Jan. 14
Historical Context
-
Evercore Healthcare Conference participation and webcast details.
-
Strong Q3 growth, margin gains, first positive adjusted EBITDA, raised guidance.
-
Nationwide GLP‑1 prescribing capability and strong member growth metrics.
-
ObesityWeek real‑world GLP‑1 outcomes and persistence data.
-
Appointment of a new Chief Medical Officer to lead clinical strategy.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morgan Healthcare Conference, taking place in San Francisco, including a presentation on Wednesday, Jan. 14, at 9 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event.
About Omada Health
Omada Health (Nasdaq: OMDA) is a virtual between-visit healthcare provider that addresses cardiometabolic conditions like diabetes, hypertension, prediabetes, and obesity, as well as musculoskeletal issues. Through specialized care tracks, Omada also supports members taking GLP-1s and other anti-obesity medications. Our unique approach of Compassionate Intelligence combines human-led care teams, connected devices, and AI-powered technology to deliver personalized care at scale.
With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada has served over one million members since launch across more than 2,000 customers, including pharmacy benefit managers, health plans, health systems, and employers ranging in size from small businesses to Fortune 500s. Its evidence-based approach and commitment to bending the curve of chronic disease has earned the company multiple healthcare accreditations and recognition in the industry.
As a trusted partner in the healthcare ecosystem, Omada delivers measurable results that help to improve health outcomes and to manage healthcare costs. For more information, visit omadahealth.com.
Contacts
Allan Kells
IR@omadahealth.com
Rose Ramseth
press@omadahealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.